Evidence map›Paper›PMID 42092730›Full record

ArticleThe Journal of molecular diagnostics : JMD2026

Validation of MyHPVscore: A High-Performance Human Papillomavirus Circulating Tumor DNA Laboratory-Developed Test.

Jordan Currie, Heather Walline, Colleen G Hochfelder, Chandan Bhambhani, Collin V Brummel, Erin Sandford, Apurva Bhangale, Rawan Akhdar, Marisa Buchakjian, Keith A Casper and 15 more

Abstract readValidation Study
In one paragraph

Article in The Journal of molecular diagnostics : JMD, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Jordan CurrieDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan; Cellular and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, Michigan.
Heather WallineDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan.
Colleen G HochfelderDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan.
Chandan BhambhaniHematology/Oncology Division, Department of Internal Medicine, University of Michigan Cancer Center, Ann Arbor, Michigan.
Collin V BrummelDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan.
Erin SandfordHematology/Oncology Division, Department of Internal Medicine, University of Michigan Cancer Center, Ann Arbor, Michigan.
Apurva BhangaleDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan.
Rawan AkhdarDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan.
Marisa BuchakjianDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Keith A CasperDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Steven B ChinnDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
David FornerDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Kelly M MalloyDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Jennifer L ShahRogel Cancer Center, University of Michigan, Ann Arbor, Michigan; Department of Radiation Oncology, University of Michigan Cancer Center, Ann Arbor, Michigan.
Andrew G ShumanDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Chaz L StuckenDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Matthew E SpectorDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Francis P WordenHematology/Oncology Division, Department of Internal Medicine, University of Michigan Cancer Center, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Pratyusha YalamanchiDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan.
Molly Heft NealDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Paul L SwiecickiHematology/Oncology Division, Department of Internal Medicine, University of Michigan Cancer Center, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Muneesh TewariHematology/Oncology Division, Department of Internal Medicine, University of Michigan Cancer Center, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Michelle L MierzwaRogel Cancer Center, University of Michigan, Ann Arbor, Michigan; Department of Radiation Oncology, University of Michigan Cancer Center, Ann Arbor, Michigan.
Mark E PrinceDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
J Chad BrennerDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan; Cellular and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan. Electronic address: chadbren@umich.edu.

Funding

Cellular and Molecular Biology at MichiganT32GM145470 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI John Chadwick Brenner · 2022 to 2026
$4.1M
Defining the Role of HPV Integration Structures in HNSCC Molecular HeterogeneityR01DE032699 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI John Chadwick Brenner, RYAN E MILLS · 2024 to 2026
$1.8M
NIDCR NIH HHS R01 DE032699NIGMS NIH HHS T32 GM145470
6 · The paper itself

Abstract

As rates of human papillomavirus-positive (HPV

Indexed as

Circulating Tumor DNAHuman Papillomavirus VirusesOropharyngeal NeoplasmsPapillomaviridaePapillomavirus InfectionsPolymerase Chain ReactionDNA, ViralFemaleHumansReproducibility of ResultsSensitivity and SpecificityCirculating Tumor DNADNA, Viral

Identifiers

PMID42092730
PMCPMC13494182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.